TH17-PRONE CD146+CCR5+ T-CELL POPULATION AS AN EARLY MARKER OF INTESTINAL GRAFT-VERSUS-HOST DISEASE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15546979

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Th17-prone CD146+CCR5+ T-cell population as an early biomarker of intestinal graft-versus-host disease and its use for determining prognosis of intestinal GVHD before the clinical signs are apparent are disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION351 WEST 10TH STREET INDIANAPOLIS IN 46202

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Peczesny, Sophie Indianapolis, US 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation